New Health Measures in CKD Management
HCPLive
DECEMBER 30, 2024
Panelists discuss the new health measures relevant to chronic kidney disease (CKD) management and their significance in improving patient care and outcomes.
105 
Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care
Cardiometabolic Health Congress
JUNE 24, 2024
The majority of learners indicated plans to use this information to enhance patient care, including adopting weight-neutral medications and encouraging lifestyle modifications. “We We are thrilled to share the outcome of this webcast series,” commented Dr. Agarwal, presenting author and Clinical Director, CMHC.
The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC)
Cardiometabolic Health Congress
JULY 25, 2024
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The future of care demands a holistic approach.
Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device
DAIC
APRIL 9, 2024
Left untreated, tricuspid regurgitation can lead to atrial fibrillation , heart failure , kidney disease and even death. Our mission of providing complete, efficient and high-quality care to the patients we care for is what drives us to lead the field.” Rogers , professor of cardiovascular medicine.
Cardiometabolic Health Congress Becomes First Organization to Offer Certification in Cardiometabolic Health
Cardiometabolic Health Congress
NOVEMBER 8, 2023
2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. Eckel, MD , chair of the Foundations of Cardiometabolic Health Certificate Course, has held appointments such as the Charles A.
Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1)
Cardiometabolic Health Congress
AUGUST 8, 2024
One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patient care and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.
2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices
Cardiometabolic Health Congress
JULY 17, 2024
Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health.
Let's personalize your content